EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Long-Acting Injectable HIV Therapy Outcomes Among Persons With HIV Who Have Adherence Challenges to Oral Antiretroviral Therapy

Elizabeth Hastie iD, Lucas Hill, Laura Bamford, Afsana Karim, Thomas C S Martin

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf120 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Elizabeth Hastie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California-San Diego, San Diego, California, USA. Hauptthemen laut MEDLINE: HIV Infections, Rilpivirine, Anti-HIV Agents, Medication Adherence. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-acting injectable cabotegravir/rilpivirine (LAI-CAB/RPV) may improve outcomes among persons with human immunodeficiency virus (PWH) with adherence difficulties to oral therapy. In this real-world observational study, over 85% of PWH remained on therapy and virally suppressed 48 weeks after initiating LAI-CAB/RPV. Providers should consider LAI therapy among PWH with adherence difficulties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsRilpivirineAnti-HIV AgentsMedication AdherencePyridonesHumansMaleFemaleAdministration, OralAdultMiddle AgedTreatment OutcomeDelayed-Action PreparationsInjectionsViral LoadDiketopiperazines

Stichwörter der Autor:innen

adherence challengescabotegravir-rilpivirinelong-acting injectablespeople with HIVviremia

Substanzen

cabotegravirRilpivirineAnti-HIV AgentsPyridonesDelayed-Action PreparationsDiketopiperazines

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California-San Diego, San Diego, California, USA.
  • Department of Medicine, Division of Infectious Diseases and Global Public Health, Veterans Affairs-San Diego, San Diego, California, USA.

ORCID-Profile: Elizabeth Hastie

Förderung

  • NIAID NIH HHS

Zitieren

APA

Hastie, E., Hill, L., Bamford, L., Karim, A., & Martin, T. C. S. (2025). Long-Acting Injectable HIV Therapy Outcomes Among Persons With HIV Who Have Adherence Challenges to Oral Antiretroviral Therapy. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf120

Vancouver

Hastie E, Hill L, Bamford L, Karim A, Martin TCS. Long-Acting Injectable HIV Therapy Outcomes Among Persons With HIV Who Have Adherence Challenges to Oral Antiretroviral Therapy. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf120

BibTeX
@article{Hastie2025,
  author = {Hastie, Elizabeth and Hill, Lucas and Bamford, Laura and Karim, Afsana and Martin, Thomas C S},
  title = {Long-Acting Injectable HIV Therapy Outcomes Among Persons With HIV Who Have Adherence Challenges to Oral Antiretroviral Therapy},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf120}
}
Kostenlos starten →